Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Unknown venue

• Publication date

  1998-08-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/s0140-6736(98)07019-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.

  2009cited by this paper
• Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy.

  2009cited by this paper
• Efficacy of troglitazone on body fat distribution in type 2 diabetes.

  2000cited by this paper
• Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

  2000cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

  2000cited by this paper
• The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal

  1999cited by this paper
• Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

  1999cited by this paper
• Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.

  1999cited by this paper
• Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.

  1999cited by this paper
• The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus

  1999cited by this paper
• Effect of troglitazone on body fat distribution in type 2 diabetic patients.

  1999cited by this paper
• The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic Control

  1998cited by this paper
• Adding metformin versus insulin dose increase in insulin‐treated but poorly controlled Type 2 diabetes mellitus: an open‐label randomized trial

  1998cited by this paper
• Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

  1998cited by this paper
• Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Should insulin therapy in type 2 diabetic patients be started on an out- or inpatient basis? Results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital.

  1998cited by this paper
• Standards of Medical Care for Patients With Diabetes Mellitus

  1998cited by this paper
• Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus.

  1998cited by this paper
• Beginning Insulin Treatment of Obese Patients With Evening 70/30 Insulin Plus Glimepiride Versus Insulin Alone

  1998cited by this paper
• Cardiovascular effects of sulphonylurea derivatives

  1997cited by this paper
• UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.

  1997cited by this paper
• Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.

  1997cited by this paper
• Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

  1997cited by this paper
• Hyperinsulinemia as an independent risk factor for ischemic heart disease.

  1996cited by this paper
• Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus

  1996cited by this paper
• Comparison of Different Insulin Regimens in Elderly Patients With NIDDM

  1996cited by this paper
• Potassium channels in the cardiovascular system.

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study

  1995cited by this paper
• Absorption of Rapid-Acting Insulin in Obese and Nonobese NIDDM Patients

  1995cited by this paper
• Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

  1995cited by this paper
• Comparison of Insulin With or Without Continuation of Oral Hypoglycemic Agents in the Treatment of Secondary Failure in NIDDM Patients

  1995cited by this paper
• UK Prospective Diabetes Study (UKPDS) XI: Biochemical Risk Factors in Type 2 Diabetic Patients at Diagnosis Compared with Age‐matched Normal Subjects

  1994cited by this paper
• The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial

  1993cited by this paper
• Hypertension secondary to chlorpropamide with amelioration by changing to insulin.

  1993cited by this paper
• Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.

  1992cited by this paper
• Is Combination Sulfonylurea and Insulin Therapy Useful in NIDDM Patients?: A metaanalysis

  1992cited by this paper
• Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDM

  1992cited by this paper
• Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years

  1991cited by this paper
• Insulin plus a sulfonylurea agent for treating type 2 diabetes.

  1991cited by this paper
• Insulin and atheroma. 20-yr perspective.

  1990cited by this paper
• Long term effectiveness of photocoagulation for diabetic maculopathy

  1989cited by this paper
• Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic Subjects

  1989cited by this paper
• Sulphonylureas in the treatment of non-insulin-dependent diabetes.

  1989cited by this paper
• Effects of Combined Insulin-Sulfonylurea Therapy in type II Patients

  1989cited by this paper
• Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.

  1988cited by this paper
• [Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial].

  1988cited by this paper
• Insulin‐glyburide combination therapy for non‐insulin‐dependent diabetes mellitus: A long‐term double‐blind, placebo‐controlled trial

  1988cited by this paper
• Combined Therapy of Insulin and Tolazamide Decreases Insulin Requirement and Serum Triglycerides in Obese Patients with Noninsulin‐Dependent Diabetes Mellitus

  1987cited by this paper
• Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea

  1987cited by this paper
• Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus.

  1986cited by this paper
• Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up.

  1986cited by this paper
• Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.

  1985cited by this paper
• The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes.

  1984cited by this paper
• Diabetes incidence in Pima indians: contributions of obesity and parental diabetes.

  1981cited by this paper
• Hyperglycaemia and coronary heart disease: the Whitehall study.

  1979cited by this paper
• Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

  1979cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper
• Insulin and atherosclerosis.

  1969cited by this paper

• DEPRESSÃO EM PACIENTES COM DIABETES MELLITUS TIPO 2: UMA REVISÃO NARRATIVA

  2026cites this paper
• Optimal Target Level of Glycosylated Hemoglobin (HbA1c) for Reducing Cardiovascular Mortality in Patients with Diabetic Nephropathy: A Systematic Review

  2026influential citation
• Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes

  2026cites this paper
• Development and validation of a multivariable prediction model for non-invasive discrimination between diabetic and non-diabetic kidney disease in type 2 diabetes: a clinical nomogram

  2026cites this paper
• Medical Management of Peripheral Arterial Disease

  2026cites this paper
• Role and mechanisms of vascular smooth muscle cell phenotypic transition in diabetic macrovascular complications

  2026cites this paper
• Impaired lymphangiogenesis in pericoronary adipose tissue correlates with diabetes-aggravated coronary atherosclerosis

  2026cites this paper
• Epigenetic regulation in type II diabetes: linking molecular mechanisms to clinical management

  2026cites this paper
• Identifying high-risk combinations of metformin during COVID-19.

  2026cites this paper
• Diabetes and its complications: molecular mechanisms, prevention and treatment

  2026cites this paper
• Comparative Effectiveness of Second-Line Oral Antidiabetic Drugs Added to Metformin Monotherapy in People with Type 2 Diabetes

  2026cites this paper
• Smartphone application-based interventions for cardiometabolic risk factor management: A systematic review and meta-analysis

  2025influential citation
• Association of hyperuricaemia and hyperglycaemia with risk of in-hospital mortality in acute aortic dissection: a multicentre cohort study in the Han Chinese population

  2025cites this paper
• Efficacy of intermittently scanned continuous glucose monitoring in patients with types 1 or 2 diabetes receiving insulin therapy: a systematic review and meta-analysis

  2025cites this paper
• Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Expert Consensus Recommendations for Optimized Diabetes Care: Dapagliflozin and Sitagliptin Fixed-dose Combination in Indian Clinical Practice

  2025cites this paper
• Optimizing Diabetes Care: The Role of Educational Interventions in Type 2 Diabetes Management

  2025influential citation
• Mechanisms of diabetic cardiomyopathy: Focus on inflammation

  2025influential citation
• Impact of Selective Peroxisome Proliferator-Activated Receptor (PPAR)-α Modulators and Fibrates on Microvascular Disease: Is There Still Room?

  2025cites this paper
• U-shaped association between social media usage frequency and suggestibility by internet health information in Chinese online population with pre-diabetes and diabetes: a cross-sectional study

  2025cites this paper
• Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique

  2025cites this paper
• Exogenous vs Endogenous Insulin Delivery: 2025

  2025cites this paper
• Risk Factors for Recurrent Vitreous Hemorrhage After 25-Gauge Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy

  2025cites this paper
• Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study

  2025cites this paper
• Modern antidiabetic therapy by sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors against cardiovascular diseases

  2025cites this paper
• Measuring Hemoglobin A1C with Frozen Packed Cell and Frozen Whole Blood Samples in an Epidemiologic Study: The Reasons for Geographic and Racial Differences in Stroke Study

  2025cites this paper
• Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study

  2025cites this paper
• Associations of dietary insulin load and dietary insulin index with diabetic nephropathy and reduced kidney function among women: a case–control study

  2025cites this paper
• Glycemic Control in Patients with Employer-Sponsored Health Benefits

  2025cites this paper
• Validation of a predictive calculator for optimal glycemic control and time-in-tight-range following CGM sensor placement in type 1 diabetes and pancreatic diabetes: a prospective study

  2025cites this paper
• The Association Between Depression and Antidiabetic Treatments in Type 2 Diabetes Patients with Both Good and Poor Glycemic Control

  2025cites this paper
• Differences in prevalence and risk factors of diabetic retinopathy among rural and urban residents with diabetes in South China: a cross-sectional study

  2025cites this paper
• Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER Trials

  2025cites this paper
• Integrated Multidisciplinary Management of Diabetes Mellitus: Roles of Internal Medicine, Hematology, Nursing, Dental Care, Optometry, Health Informatics, Hospital Management, and Social Work

  2025cites this paper
• The effect of diabetes on complications after distal pancreatectomy: A population-based cross-matched registry study

  2025cites this paper
• Autonomic neuropathy in diabetes

  2025cites this paper
• Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Management of Diabetes Mellitus: A Review

  2025cites this paper
• External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness

  2025influential citation
• Real-World Effectiveness of Different Nutraceutical Formulations on Pain Intensity of Subjects with Diabetic Peripheral Neuropathy: An Observational, Retrospective, Case–Control Study

  2025cites this paper
• Associations of body fat and inflammation with non-communicable chronic diseases and mortality: a prospective cohort study of the UK Biobank

  2025cites this paper
• Therapeutic tailored approach in patients with diabetes, cardiovascular and renal comorbidities: A cardiologist's view.

  2025cites this paper
• An overview of the FreeStyle Libre monitoring system for individuals with type 1 and type 2 diabetes

  2025cites this paper
• AVANCES EN EL TRATAMIENTO DE LA DIABETES EN EL SIGLO XXI

  2025cites this paper
• Causal associations between HbA1c and multiple diseases unveiled through a Mendelian randomization phenome-wide association study in East Asian populations

  2025cites this paper
• Indole metabolism and its role in diabetic macrovascular and microvascular complications

  2025cites this paper
• Renal Status in Newly Diagnosed Patients with Diabetes Mellitus: A Descriptive Study in Primary Care and Opportunities for Improving Management

  2025cites this paper
• Blood pressure variability is associated with the occurrence of diabetic microangiopathy in type 2 diabetes mellitus: a cross-sectional study

  2025cites this paper
• Evaluating Genetic Obesity Interventions: A Survival Analysis Approach

  2025cites this paper
• The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes: findings from a large UK study

  2025cites this paper
• Correlation of HbA1c and Continuous Glucose Monitor Time in Range

  2025influential citation
• Irisin regulates integrin αvβ5/FAK/ERK to inhibit neutrophil extracellular traps formation and reduce pancreatic beta-cells pyroptosis in type 2 diabetes mellitus

  2025cites this paper
• Metabolic surgery versus usual care effects on mortality among patients with obesity and type 2 diabetes: A systematic review and meta-analysis

  2025cites this paper
• Predicting the need for diabetic macular oedema treatment from photographic screening in the Singapore Integrated Diabetic Retinopathy Programme (SiDRP)

  2025cites this paper
• A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.

  2025cites this paper
• Cost–Utility Analysis of FreeStyle Libre Systems in People with Type 2 Diabetes Mellitus on Treatment with Basal Insulin and Poor Glycemic Control in Spain

  2025cites this paper
• Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosis

  2025cites this paper
• The overlap of diabetic and inflammatory neuropathies: Epidemiology, possible mechanisms, and treatment implications.

  2025cites this paper
• Cerebral microbleeds and renal dysfunction: Degenerative neurobiological shared mechanisms within intracerebral hemorrhage.

  2025cites this paper
• The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada

  2025influential citation
• Decoding the coronary paradox of obesity: not all fat is equal!

  2025cites this paper
• Metformin ameliorates blunted cardioprotective response of ischemic postconditioning in rats subjected to high fat diet

  2025cites this paper
• Diabetic kidney disease: from pathogenesis to multimodal therapy–current evidence and future directions

  2025cites this paper
• Benchmarking progress in non-communicable diseases: a global analysis of cause-specific mortality from 2001 to 2019

  2025cites this paper
• Awareness, treatment, and control of diabetes in South America: A systematic review and meta-analysis

  2025cites this paper
• Incidence of Treatment Delays among Patients with Diabetes: A Clinic-based Cross-sectional Descriptive Study in India.

  2025cites this paper
• Development and validation of a machine learning model for cardiovascular disease risk prediction in type 2 diabetes patients

  2025cites this paper
• Accuracy of continuous glucose monitoring in critically ill patients

  2025cites this paper
• SUN-625 Valsartan Induced Severe Hypoglycemia in a Non-diabetic Patient

  2025cites this paper
• Beyond Glycemic Control: Vascular Biologic Effects of Antidiabetic Drugs and Their Cardiovascular Promise

  2025cites this paper
• Correlation of C-Peptide Levels With Complications of Type 2 Diabetes Mellitus

  2025cites this paper
• Eye and Systemic Disease Management Changes After Teleophthalmology Screening in Primary Care: Retrospective Cross-Sectional Pilot Study of 200 Consecutive Patients

  2025cites this paper
• Incidence of treatment intensification based on HbA1c trends in people with type 2 diabetes

  2025cites this paper
• Pharmacology and Clinical Efficacy of Semaglutide in the Management of Type 2 Diabetes Mellitus

  2025cites this paper
• Efficacy of structured exercise protocol on functional capacity, HbA1c, and waist-hip ratio in post-myocardial infarction subjects with diabetes mellitus

  2025cites this paper
• Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents

  2024cites this paper
• Metabolic memory: mechanisms and diseases

  2024cites this paper
• Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study

  2024cites this paper
• Impact of Bariatric Surgery on Treatment Burden and Progression of Diabetic Retinopathy

  2024cites this paper
• An Insight into the Approach Taken to Appurtenances Disorders Linked to Mitochondria

  2024cites this paper
• Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attending selected healthcare institutions in Colombia

  2024cites this paper
• Removing Barriers, Bridging the Gap, and the Changing Role of the Health Care Professional with Automated Insulin Delivery Systems

  2024cites this paper
• Evaluation of diabetic foot care knowledge, determinants of self‐care practices and the efficacy of health education

  2024cites this paper
• Observational, Multicenter, Retrospective, Study on the Usage Patterns of the Fixed Dose Combination of Glimepiride, Metformin, and Voglibose in Type 2 Diabetes Management

  2024cites this paper
• Assessment of equations estimating average glucose among patients with diabetic kidney disease before dialysis

  2024cites this paper
• Dietary Practices Among Type 2 Diabetes Patients Visiting a Non-communicable Disease (NCD) Clinic in a District of Western India: A Cross-Sectional Study

  2024cites this paper
• A Narrative Review of Retinopathy in Diabetic Patients

  2024cites this paper
• A short-term economic evaluation of early insulin therapy compared to oral anti-diabetic drugs in order to reduce the major adverse events in type 2 diabetes patients in Iran

  2024cites this paper
• Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive Value

  2024cites this paper
• Clinical Pharmacists´ Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review

  2024cites this paper
• 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025.

  2024cites this paper
• Identifying subgroups benefiting from intensive glycaemic treatment to improve renal outcomes in type 2 diabetes: Insights from the ACCORD trial

  2024cites this paper
• Stable Angina Pectoris: A Review of Pathophysiology, Diagnosis, and Its Management.

  2024cites this paper
• Unlocking the potential of glucagon-like peptide-1 receptor agonists in revolutionizing type 2 diabetes management: a comprehensive review

  2024cites this paper
• Newer Insulin Preparations and Insulin Analogs

  2024cites this paper
• Insulin Resistance, Hyperinsulinemia and Atherosclerosis: Insights into Pathophysiological Aspects and Future Therapeutic Prospects

  2024influential citation
• Estrategia terapéutica en el paciente diabético (II). Tratamiento farmacológico del paciente con diabetes mellitus tipo 2. Criterios de selección y evidencia actual de los fármacos antidiabéticos no insulínicos

  2024cites this paper
• Profiles of Peripheral Neuropathy and Risk Factors in People With Treatment-Naive Type 2 Diabetes Mellitus and Prediabetes

  2024cites this paper
• 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2025.

  2024cites this paper
• Medidas de ocorrência de diabetes mellitus e suas complicações crônicas: caracterização da oferta e demanda de serviços de saúde para Amazonas, Rio Grande do Sul e Brasil, 2012

  2024cites this paper
• Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study

  2024cites this paper